Qiagen announces the acquisition of an enabling technology for enrichment and molecular analysis of circulating tumor cells (CTCs) from blood samples

March 17, 2015 Leave a comment 3,473 Views

GERMANTOWN, Maryland, and HILDEN, Germany, March 16, 2015 /PRNewswire/ — Acquisition of technology from AdnaGen enables use of innovative, non-invasive blood tests to analyze circulating tumor cells (CTCs) for personalized healthcare QIAGEN and Tokai Pharmaceuticals to co-develop and commercialize the ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: AdnaGen

Qiagen announces the acquisition of an enabling technology for enrichment and molecular analysis of circulating tumor cells (CTCs) from blood samples

Extracellular vesicles released following exercise in healthy men could indicate muscle damage

Single EV analysis (sEVA) of mutated proteins allows early detection of pancreatic cancer

Spartina Biotechnologies raises money for exosome technology designed to impede Covid-19 and other viruses

Extracellular vesicles synchronize cellular phenotypes of differentiating cells

Featured Exosome Job – Research Scientist – Extracellular Vesicle and Cancer Nanotechnology

Exosomes & EVs – Isolation, Characterization, Machine Learning for RNA diagnostics